Hepatitis Delta Virus
📧 Sign up to get email alerts when something new happens for Hepatitis Delta Virus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy Participants [Phase 1]
A Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of ABI-6250 in healthy participants for hepatitis D is reported as…
-
CLINICAL_TRIALS trial_result · 2023-08-25Clinical Trial Update: Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV [Phase 3]
Phase 3 trial evaluating Peginterferon Lambda for 48 weeks in patients with Hepatitis Delta Virus is underway (status unknown).
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a [Phase 3]
Phase 3 trial evaluating lonafarnib/ritonavir with and without pegylated interferon alfa-2a for hepatitis delta virus has completed.